| | | |
Webcasts
Filling in the Gaps of Early Drug Discovery with High-Throughput Label-Free Biosensors: Hope, Hype or Truth?
30 November 2009
Julio Jose Martin, Manager Screening and Compound Profiling, GlaxoSmithKline, Screening Europe 2009
|
|
A Structural View on Protein Kinase CK2 and its Potential Role as a Target for Small Molecules
30 November 2009
Karsten Niefind, University of Cologne, speaking at Screening Europe 2009
|
|
Fragment Based Drug Discovery of Novel MK2 Inhibitors
19 November 2009
Thomas Hesterkamp, VP Fragment Based Drug Discovery, Evotec AG, speaking at MedChem Europe 2009
|
|
Development of DIBENZOSUBERONES as Potent and Highly Selective p38 MAPK Inhibitors
19 November 2009
Stefan Laufer, Professor, Department Head, Eberhard-Karls-University Tuebingen, speaking at MedChem Europe 2009
|
|
Advancing Drug Discovery in an Academic Setting
05 November 2009
Julie Frearson, Professor Biotechnology/Drug Discovery/Biological Chemistry and Molecular Pharmacology, University of Dundee, speaking at Screening Europe 2009
|
|
Impedance-Based Measurement of GPCR Modulators in Drug Discovery – Characterization of Signalling Pathways in Recombinant and Non-Recombinant Cells
05 November 2009
John Gatfield, Senior Lab Head Molecular Biology, Actelion Pharmaceuticals Ltd, speaking at Screening Europe 2009
|
|
De Novo Molecular Design: A Powerful Strategy for the Discovery of New Potential Antimalarials and Antibacterials
09 October 2009
Colin Fishwick, Reader/ Director Organic Chemistry/Leeds Structure-Based Drug Design Group, University of Leeds School of Chemistry, speaking at MedChem Europe 2009
|
|
Intersecting Biological and Chemical Knowledge for Computational Toxicology
02 October 2009
Florian Nigsch, Research Associate, University of Cambridge, speaking at ADMET Europe 2009
|
|
Bioluminescent Cytochrome P450 Inhibition and Induction Assays: Comparisons to Conventional Methods
18 August 2009
Jim Cali, Senior Scientist, Promega, speaking at ADMET Europe 2009
|
|
In silico Prediction of ADMET Properties
18 August 2009
John Dearden, School of Pharmacy and Chemistry, Liverpool John Moores University, speaking as ADMET Europe 2009
|
|
| |
| |
|